Tulavi Therapeutics
Pre-clinicalTulavi’s innovative Adaptive Hydrogel Technology is engineered to support nerve healing to address poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair.
Founded
2021
Focus
Neuroscience
About
Tulavi’s innovative Adaptive Hydrogel Technology is engineered to support nerve healing to address poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair.
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile